FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

398967000: Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine (medicinal product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1778441012 Hydralazine hydrochloride + hydrochlorothiazide + reserpine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3490636011 Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3494831014 Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3837321000005115 hydralazinhydrochlorid + hydrochlorthiazid + reserpin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    hydralazinhydrochlorid + hydrochlorthiazid + reserpin Is a Product containing hydrochlorothiazide and reserpine (medicinal product) false Inferred relationship Some
    hydralazinhydrochlorid + hydrochlorthiazid + reserpin Is a Product containing hydralazine (medicinal product) false Inferred relationship Some
    hydralazinhydrochlorid + hydrochlorthiazid + reserpin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrochlorothiazide (substance) false Inferred relationship Some
    hydralazinhydrochlorid + hydrochlorthiazid + reserpin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Reserpine (substance) false Inferred relationship Some
    hydralazinhydrochlorid + hydrochlorthiazid + reserpin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Centrally acting hypotensive agent (substance) false Inferred relationship Some
    hydralazinhydrochlorid + hydrochlorthiazid + reserpin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydralazine hydrochloride false Inferred relationship Some
    hydralazinhydrochlorid + hydrochlorthiazid + reserpin Is a Hydralazine-containing product in oral dose form false Inferred relationship Some
    hydralazinhydrochlorid + hydrochlorthiazid + reserpin Has manufactured dose form Oral dose form false Inferred relationship Some
    hydralazinhydrochlorid + hydrochlorthiazid + reserpin Is a vasodilaterende middel false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Is a False hydralazinhydrochlorid + hydrochlorthiazid + reserpin Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start